News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
PharmaPraxis, from Axis Biotec Brazil, Will Be Present at the Biotechnology Industry Organization (BIO) 2012 INTERNATIONAL CONVENTION in Boston
June 14, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RIO DE JANEIRO, Brazil--(BUSINESS WIRE)--Eduardo Cruz, PharmaPraxis´ CEO, will be a speaker in the breakout session on the 18th of June. Dr Cruz will speak about the Brazilian current innovation model for the biotechnology sector.
Twitter
LinkedIn
Facebook
Email
Print
Events
South America
Biotechnology Innovation Organization (BIO)
MORE ON THIS TOPIC
ALS
QurAlis’ Phase 2 data bolster case for genetic approach to sporadic ALS
May 5, 2026
·
4 min read
·
Heather McKenzie
Cancer
AACR 2026: Combo therapies by Moderna, Marengo show promise in skin, breast cancer
April 28, 2026
·
5 min read
·
Andrea Park
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
April 27, 2026
·
5 min read
·
Heather McKenzie
Cancer
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
April 17, 2026
·
5 min read
·
Nick Paul Taylor